Corporate Milestones
The Evolution of NHB Korea
From Local Foundation to Global Expansion
Phase 4. Market Consolidation & Innovation (2024 – 2026)
2026
Received KOSME Award (Korea SMEs and Startups Agency)
Exclusive Wholesale Agent for Nature Republic in Vietnam
2025
Major OEM Project: Color Cosmetics (Mongolia & Vietnam)
Strategic Sourcing: 3,000 SKU Portfolio (Philippines)
Launched HOSUNJUNG™ (Proprietary Brand)
ODM Export: Arutox™ Detox Juice (Mongolia)
Certified as a Venture Enterprise
Received GBSA Award (Gyeonggi Business & Science Accelerator)
Published Research in SCI Journals (Journal of Medical Food / Molecular Medicine Report)
Phase 3. Global Expansion & Strategic Partnerships (2022 – 2023)
2023
Exclusive Supply Agreement with Nature Republic (Vietnam)
Selected as KRIBB Family Company
Launched ENGEVITA
2022
Established China Branch (Hangzhou)
Secured Humulus Japonicus (HSy2) Exclusive Contract
Strategic Distribution Partnership: Dongwha Pharm, Bioleaders
Relocated HQ to Goyang ARC Biz Center
Phase 2. Corporate Growth & Scale-up (2020 – 2021)
2021
Reached Annual Revenue of USD 6.8 Million
Global Wholesale Network Expansion (CIS, Asia, Oceania)
Semi-exclusive Agreement with Nutrione
Incorporated as NHB Co., Ltd.
Phase 1. The Foundation (2014 – 2016)
2016
Registered Proprietary Brand OGAJUNG™
2015
Filed Patent for Acanthopanax Senticosus Extract
2014
Established NEO H&B
Patent & Paper
Patents
Method for Manufacturing Concentrate Composition Containing Eleutherococcus senticosus (Siberian ginseng) (Registration No. 10-2696923, South Korea)
Publications (SCI Journals)
Journal of Medical Food, 28(11) 2025, 1135-1146. “Water extract of Humulus japonicus improves age-related cognitive decline by inhibiting acetylcholinesterase activity and the acetylcholine signaling pathway.”
Molecular Medicine Reports, 31:131, 2025. “Humulus japonicus water extract inhibits neuroinflammation through the p38 MAPK signaling pathway in a systemic LPS-injection mice model.
Journals Download
